These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways. Peyssonnaux C, Provot S, Felder-Schmittbuhl MP, Calothy G, Eychène A. Mol Cell Biol; 2000 Oct 30; 20(19):7068-79. PubMed ID: 10982823 [Abstract] [Full Text] [Related]
3. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21. Rosário M, Paterson HF, Marshall CJ. Mol Cell Biol; 2001 Jun 30; 21(11):3750-62. PubMed ID: 11340168 [Abstract] [Full Text] [Related]
4. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes. Genot E, Reif K, Beach S, Kramer I, Cantrell D. Oncogene; 1998 Oct 01; 17(13):1731-8. PubMed ID: 9796702 [Abstract] [Full Text] [Related]
5. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras. Oliva JL, Zarich N, Martínez N, Jorge R, Castrillo A, Azañedo M, García-Vargas S, Gutiérrez-Eisman S, Juarranz A, Boscá L, Gutkind JS, Rojas JM. J Biol Chem; 2004 Aug 06; 279(32):33480-91. PubMed ID: 15181015 [Abstract] [Full Text] [Related]
6. Regulation of Ras signaling by the cell cycle. Stacey D, Kazlauskas A. Curr Opin Genet Dev; 2002 Feb 06; 12(1):44-6. PubMed ID: 11790553 [Abstract] [Full Text] [Related]
7. Ras signals principally via Erk in G1 but cooperates with PI3K/Akt for Cyclin D induction and S-phase entry. Vasjari L, Bresan S, Biskup C, Pai G, Rubio I. Cell Cycle; 2019 Jan 06; 18(2):204-225. PubMed ID: 30560710 [Abstract] [Full Text] [Related]
8. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ. Mol Cell Biol; 1996 Jul 06; 16(7):3923-33. PubMed ID: 8668210 [Abstract] [Full Text] [Related]
13. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD. Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018 [Abstract] [Full Text] [Related]
15. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Geppert TD, Whitehurst CE, Thompson P, Beutler B. Mol Med; 1994 Nov 28; 1(1):93-103. PubMed ID: 8790605 [Abstract] [Full Text] [Related]
16. TC21 causes transformation by Raf-independent signaling pathways. Graham SM, Vojtek AB, Huff SY, Cox AD, Clark GJ, Cooper JA, Der CJ. Mol Cell Biol; 1996 Nov 28; 16(11):6132-40. PubMed ID: 8887643 [Abstract] [Full Text] [Related]
17. Transcriptional regulation of the TATA-binding protein by Ras cellular signaling. Johnson SA, Mandavia N, Wang HD, Johnson DL. Mol Cell Biol; 2000 Jul 28; 20(14):5000-9. PubMed ID: 10866657 [Abstract] [Full Text] [Related]
18. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Sun H, King AJ, Diaz HB, Marshall MS. Curr Biol; 2000 Mar 09; 10(5):281-4. PubMed ID: 10712905 [Abstract] [Full Text] [Related]
19. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Marte BM, Rodriguez-Viciana P, Wennström S, Warne PH, Downward J. Curr Biol; 1997 Jan 01; 7(1):63-70. PubMed ID: 8999998 [Abstract] [Full Text] [Related]